OCTEVY Trademark

Trademark Overview


On Tuesday, September 14, 2021, a trademark application was filed for OCTEVY with the United States Patent and Trademark Office. The USPTO has given the OCTEVY trademark a serial number of 97026754. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, October 15, 2024. This trademark is owned by Evergreen Theragnostics, Inc.. The OCTEVY trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical preparations; Diagnostic Radiopharmaceuticals agents for use in the field of nuclear medicine; Radiopharmaceuticals agents for use in the field of nuclear medicine, intended for medical imaging; Injectable diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical agents for use in PET imaging; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceutical preparations, in particular gallium coordination complexes and gallium DOTATOC for detecting cancer; Cold kit being gallium coordination complexes and gallium DOTATOC for use in imaging of neuroendocrine tumors
octevy

General Information


Serial Number97026754
Word MarkOCTEVY
Filing DateTuesday, September 14, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Goods and ServicesDiagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical preparations; Diagnostic Radiopharmaceuticals agents for use in the field of nuclear medicine; Radiopharmaceuticals agents for use in the field of nuclear medicine, intended for medical imaging; Injectable diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical agents for use in PET imaging; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceutical preparations, in particular gallium coordination complexes and gallium DOTATOC for detecting cancer; Cold kit being gallium coordination complexes and gallium DOTATOC for use in imaging of neuroendocrine tumors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEvergreen Theragnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSpringfield, NJ 07081

Party NameEvergreen Theragnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSpringfield, NJ 07081

Trademark Events


Event DateEvent Description
Wednesday, April 27, 2022EXAMINERS AMENDMENT E-MAILED
Friday, September 17, 2021NEW APPLICATION ENTERED
Wednesday, October 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 20, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 27, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, April 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022NEW NOA TO ISSUE
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 10, 2023SOU EXTENSION 1 FILED
Wednesday, May 10, 2023SOU EXTENSION 1 GRANTED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 2 FILED
Thursday, November 16, 2023SOU EXTENSION 2 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024SOU EXTENSION 3 FILED
Tuesday, April 16, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2024SOU EXTENSION 4 GRANTED
Tuesday, October 15, 2024SOU EXTENSION 4 FILED